Filing Details

Accession Number:
0001181431-13-009830
Form Type:
5
Zero Holdings:
No
Publication Time:
2013-02-14 17:51:37
Reporting Period:
2012-12-31
Filing Date:
2013-02-14
Accepted Time:
2013-02-14 17:51:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544116 Durata Therapeutics Inc. DRTX Pharmaceutical Preparations (2834) 871247903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553593 W. Michael Dunne C/O Durata Therapeutics, Inc.
200 South Wacker Drive, Suite 2550
Chicago IL 60606
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-24 2,000 $9.00 13,220 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct